MRI-guided radiation to reduce dry mouth from head and neck cancer treatment
Part of Cancer clinical trials.
This trial tests if using an MRI to map saliva glands before radiation can help spare them, reducing dry mouth. It is for people with oropharynx cancer who will receive radiation with or without chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have oropharynx cancer (stage T0-4, N0-3, M0) that will be treated with radiation, possibly with chemotherapy.
- Be 18 years or older.
- Be able to have an MRI scan (no metal implants or claustrophobia issues).
- Have a performance status of 0, 1, or 2 (able to carry out daily activities with some help if needed).
- If you can become pregnant, agree to use highly effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how radiation therapy for head and neck cancer changes your sense of taste and saliva. It aims to better understand and manage these side effects.
This trial is testing a new way to use radiation therapy for head and neck cancer by also looking at the bacteria in your mouth and gut. The goal is to see if adjusting the treatment based on your bacteria can improve outcomes and reduce side effects.
This trial uses advanced imaging (MRI scans) to see how radiation therapy affects the salivary glands in people being treated for nasopharyngeal cancer. The goal is to find better ways to prevent or manage dry mouth and other side effects.
This study uses special MRI scans to monitor how the parotid gland (a saliva gland near the jaw) is affected by radiation therapy for nasopharyngeal cancer. The goal is to better understand and possibly reduce side effects like dry mouth.
This trial compares a new radiation technique designed to reduce dry mouth (xerostomia) with standard radiation for people with nasopharyngeal cancer. It aims to see if the new approach can protect saliva glands while still treating the cancer effectively.
This trial tests a new daily adaptive radiotherapy technique that aims to spare the submandibular salivary glands during head and neck cancer treatment. It may help reduce dry mouth after radiation.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.